Cancer cell lines and animal models

How do preclinical ivermectin dosing levels in mice compare with human pharmacokinetic tolerability in oncology studies?

Preclinical mouse studies of ivermectin report effective antitumor activity across a wide dose range—commonly 0.5–10 mg/kg and in some reviews up to 40 mg/kg—with many experiments using ~3–10 mg/kg to...